GLI GLI Quality Tool
GLI Quality Tool — Version 2.0

Building a TB specimen retention policy that stands up to scrutiny

A clear specimen retention policy helps a tuberculosis laboratory preserve evidence, support reliable audits and make ethically approved research possible. It should explain which specimens are kept, for how long, under what conditions and who may access them. Without those decisions in writing, valuable material can be discarded too early or stored indefinitely without proper governance.

For TB services, retention covers more than a sputum container in a refrigerator. It may include original specimens, processed material, culture isolates, extracted nucleic acid, slides, digital images and associated records. Each type has a different safety profile, storage requirement and future value. The policy should therefore connect laboratory practice with biosafety, privacy, quality management and research approval.

The GLI Quality Tool provides a practical way to build this work into a broader quality management system. Its four-phase roadmap and twelve Quality Systems Essentials can help a laboratory move from defining responsibilities and documenting processes to monitoring performance and pursuing continual improvement. The approach is suitable for large metropolitan services and smaller laboratories supporting remote Australian communities.

Define the purpose and scope

Start by stating why specimens are retained. Audit use may include investigating an amended result, confirming a quality incident, reviewing contamination, demonstrating competency or responding to an external assessment. Research use is different: it may involve method validation, surveillance, assay development or approved epidemiological studies. Combining both purposes in one vague retention rule creates confusion.

List every material covered by the policy. A useful scope may include primary respiratory specimens, blood or other samples where relevant, smears, culture isolates, positive and negative controls, extracted DNA or RNA, sequencing data and images. Include accompanying identifiers such as accession numbers, collection dates, test methods, results, storage location and disposal status.

Define exclusions as well. Routine consumables, rejected specimens and materials retained under a separate biobank arrangement may follow different procedures. In Australia, a state or territory public laboratory may need to align its policy with local health department rules, while a private provider may also need to meet contractual and accreditation requirements.

Map governance and legal requirements

Assign ownership before setting time periods. The laboratory director or clinical lead should approve the policy, while the quality manager controls the document and the specimen custodian maintains the inventory. Staff responsible for biosafety, information governance, infection prevention and research should have defined roles. A deputy is important when the usual custodian is away, particularly in smaller services.

Retention must respect privacy and health-record obligations. The Privacy Act 1988 may apply to personal information held by Australian organisations, while state and territory privacy and records laws can add requirements. A specimen linked to a patient is identifiable health information even when the tube is held in a laboratory rather than a medical record system. Use the minimum necessary identifiers and document approved access.

Research use requires separate governance from routine audit. Human Research Ethics Committee approval, participant consent or an approved waiver, data linkage controls and material transfer arrangements may be needed. A stored isolate cannot automatically be used for a new study simply because it was collected during clinical care. Record the approval reference, permitted uses, restrictions and destruction requirements.

Set defensible retention periods

Avoid choosing one period for every specimen. A schedule should distinguish between material that supports immediate clinical review and material with long-term surveillance or research value. For example, a laboratory may retain original specimens until testing is complete and quality checks are accepted, while retaining confirmed TB isolates for longer if they support resistance investigation, outbreak analysis or public health surveillance.

The final period should be approved by the laboratory’s governing organisation and checked against applicable state or territory directions, contracts, accreditation expectations and research approvals. NATA accreditation against ISO 15189 supports controlled processes and documented records, but it does not provide a universal Australian TB specimen timeframe. The laboratory must justify its own schedule.

Consider practical triggers as well as calendar periods. Retention may begin at collection, accessioning, final result authorisation or closure of an incident. A research project may require material to be held until publication, data verification or the end of a specified approval period. If a complaint, legal hold, proficiency investigation or outbreak response is active, disposal should be suspended and the reason recorded.

Design safe storage and identification

The storage plan should match the material’s risk and stability. Clinical specimens and cultures may require validated temperature ranges, restricted access, secondary containment and documented monitoring. Laboratories working with viable Mycobacterium tuberculosis need procedures consistent with Australian biosafety requirements, local risk assessments and the facility’s authorised containment arrangements.

Use a unique accession or study code rather than relying on names. A separate, access-controlled linkage file can connect the code to the patient where necessary. Labels should remain legible at the required temperature, and the laboratory should define how it handles relabelling, damaged containers, leaking specimens and uncertain identity. Two-person checks are appropriate for high-risk transfers or disposal.

Storage capacity is a real operational issue. A service in Melbourne or Sydney may have dedicated monitored freezers, whereas a regional laboratory in Queensland, Western Australia or the Northern Territory may depend on limited space and scheduled transport to a reference centre. Include backup power, alarm escalation, contingency storage and courier arrangements in the policy rather than treating them as informal knowledge.

Control access and retrieval

Create an inventory that records what exists and where it is located. At minimum, capture the specimen code, material type, collection and processing dates, storage unit, rack or box position, retention category, access history and planned disposal date. Electronic laboratory information systems can support this, but a controlled paper register may be necessary during outages or in lower-resource settings.

Every removal should have a reason and an authorised person. Record whether material was used for a repeat test, audit, referral, research, teaching or incident investigation. When a specimen is returned, document its condition and new location. If it is consumed, split, transferred or found unsuitable, update the inventory immediately.

Retrieval procedures should protect chain of custody and confidentiality. A researcher should receive only the coded material authorised by the protocol, while a clinical review may require controlled re-identification. For Aboriginal and Torres Strait Islander communities, local governance, respectful engagement and culturally safe data practices should be considered alongside general privacy controls, particularly when specimens are linked with small or remote populations.

Manage transfers and secure disposal

Transfers between laboratories need a documented handover. The record should identify the sending and receiving organisations, specimen codes, contents, packaging, transport conditions, date, courier and recipient. Australian services may use state-based networks, public hospital couriers or specialist transport providers, and the policy should state what happens if a shipment is delayed, temperature-exposed or refused.

Disposal must be deliberate, traceable and safe. Define who can authorise it, how the specimen is rendered non-infectious or destroyed, and what record is retained. Disposal methods should follow the risk assessment, local waste procedures and relevant transport or biosafety requirements. Do not place a disposal date on the calendar without checking for active investigations, legal holds, research obligations or unresolved result disputes.

A disposal log should include the specimen range, date, method, operator, verifier and reason. For large volumes, a second-person verification or electronic approval reduces the chance of deleting the wrong material. If a freezer failure causes loss, document the incident, notify affected stakeholders where required and assess whether corrective action is needed.

Review performance and improve the policy

Use audits to test whether the policy works in practice. Sample records can show whether specimens are labelled correctly, inventory locations are accurate, access is authorised and disposal is completed on time. Track indicators such as retrieval time, temperature excursions, unidentified materials, overdue disposals and discrepancies between the register and physical stock.

The GLI Quality Tool’s phase-based structure can help laboratories introduce this progressively. Early work can establish procedures, training and document control; later phases can add internal audits, management review, root-cause analysis and continual improvement. This is useful for a laboratory building capability gradually rather than trying to create a complex biobank system on day one.

Retention purpose Typical material Main control Review trigger
Clinical follow-up Original specimen, smear or extract Result authorisation and secure access Amended result, complaint or incident
Quality audit Controls, slides, isolates and records Traceability and documented access Internal or external assessment
Public health response Confirmed isolates and resistance evidence Biosafety, chain of custody and authorised sharing Cluster, outbreak or surveillance request
Approved research Coded specimens, isolates or extracts HREC approval, consent or waiver and data governance Protocol expiry, publication or approval change

Bring the policy to management review at least annually and whenever testing methods, storage equipment, legislation or research arrangements change. Train all relevant staff, including agency workers and couriers where appropriate, and retain evidence of competency. A signed policy is useful only when daily practice can demonstrate that its controls are understood and followed.

A well-designed TB specimen retention policy gives your laboratory a reliable evidence trail without creating uncontrolled storage. Use the GLI Quality Tool to map responsibilities, risks, records and improvement actions, then validate the schedule with your quality lead, biosafety adviser, privacy officer and research governance team. Put the approved procedure into practice, audit it routinely and keep each retained specimen purposeful, traceable and safe.